Zhao et al. reported that the miR-34a-5p-c/MYC/CHK1/CHK2 axis mitigated cancer stem cell-like traits and increased radiosensitivity by inhibiting the DNA damage response in HCC [135]. The gene discussed is CHEK2; the disease is hepatocellular carcinoma.